Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis Back February 17, 2025 by admin Document https://www.nejm.org/doi/full/10.1056/NEJMoa2400327?query=TOC&cid=DM2384078_Non_Subscriber&bid=-1519047293 Metadata SubjectOral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisTypeArticleTitleOral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis Continue browsing CRISPR-Based Therapy for Hereditary Angioedema E-Cigarettes at the Supreme Court — Potential Implications for the FDA and Public Health Back to items list